The DOI matches its Crossref record; 180 of the 181 references it cites were found in a registry or an index.
Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology
Open accessAbstract
The hormone islet amyloid polypeptide (IAPP, or amylin) plays a role in glucose homeostasis but aggregates to form islet amyloid in type-2 diabetes. Islet amyloid formation contributes to β -cell dysfunction and death in the disease and to the failure of islet transplants. Recent work suggests a role for IAPP aggregation in cardiovascular complications of type-2 diabetes and hints at a possible role in type-1 diabetes. The mechanisms of IAPP amyloid formation in vivo or in vitro are not understood and the mechanisms of IAPP induced β -cell death are not fully defined. Activation of the inflammasome, defects in autophagy, ER stress, generation of reactive oxygen species, membrane disruption, and receptor mediated mechanisms have all been proposed to play a role. Open questions in the field include the relative importance of the various mechanisms of β -cell death, the relevance of reductionist biophysical studies to the situation in vivo , the molecular mechanism of amyloid formation in vitro and in vivo , the factors which trigger amyloid formation in type-2 diabetes, the potential role of IAPP in type-1 diabetes, the development of clinically relevant inhibitors of islet amyloidosis toxicity, and the design of soluble, bioactive variants of IAPP for use as adjuncts to insulin therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been demonstrated that amylin analogs, such as pramlintide, dramatically lower body weight, HbA1c levels, and even insulin dosage (98, 99).”
From A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents. (2024) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to insulin monotherapy, patients with T1DM who received amylin analog in addition to insulin experienced a greater reduction in pre-prandial hyperglycemia and a corresponding decrease in glucagon levels.”
From A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents. (2024) · cites this paper as [99]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Zhou, H., Rivas, G., & Minton, A. P. (2008) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.37.032807.125817 · Cited by 2,160
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,106
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
A possible role for π‐stacking in the self‐assembly of amyloid fibrils
Gazit, E. (2002) · The FASEB Journal · doi:10.1096/fj.01-0442hyp · Cited by 1,128
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Diabetes Mellitus and the β Cell: The Last Ten Years
Ashcroft, F. M., & Rorsman, P. (2012) · Cell · doi:10.1016/j.cell.2012.02.010 · Cited by 902
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807
Poitout, V., & Robertson, R. P. (2002) · Endocrinology · doi:10.1210/endo.143.2.8623 · Cited by 743
Janson, J., Ashley, R. H., Harrison, D. J., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 614
Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 592
Saturated Fatty Acids Synergize with Elevated Glucose to Cause Pancreatic β-Cell Death
El-Assaad, W., Buteau, J., Peyot, M., Nolan, C. J., Roduit, R., Hardy, S., Joly, E. C., Dbaibo, G. S., Rosenberg, L. C., & Prentki, M. (2003) · Endocrinology · doi:10.1210/en.2003-0410 · Cited by 586
Luca, S., Yau, W., Leapman, R. D., & Tycko, R. (2007) · Biochemistry · doi:10.1021/bi701427q · Cited by 584
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Recent advances in understanding leptin signaling and leptin resistance
Morris, D. L., & Rui, L. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00274.2009 · Cited by 484
Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane
Engel, M. F., Khemtemourian, L., Kleijer, C. C., Meeldijk, H. J. D., Jacobs, J., Verkleij, A., de Kruijff, B., Killian, J., & Höppener, J. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0708354105 · Cited by 465
Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells
Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J., & Porte, D. (1990) · Diabetes · doi:10.2337/diab.39.5.634 · Cited by 454
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442
Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706473105 · Cited by 436
Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide
Rosenfeld, R., & Gazit, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102883200 · Cited by 421
Butler, A. E., Janson, J., Soeller, W. C., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2304 · Cited by 411
Lukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371
Brender, J., Salamekh, S., & Ramamoorthy, A. (2011) · Accounts of Chemical Research · doi:10.1021/ar200189b · Cited by 359
The effect of macromolecular crowding on protein aggregation and amyloid fibril formation
Munishkina, L. A., Cooper, E. M., Uversky, V. N., & Fink, A. L. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.699 · Cited by 355
Macromolecular Crowding and Protein Stability
Wang, Y., Sarkar, M., Smith, A. E., Krois, A. S., & Pielak, G. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305300m · Cited by 354
Cooper, G. J. S., Leighton, B., Dimitriadis, G., Parry‐Billings, M., Kowalchuk, J. M., Howland, K., Rothbard, J. B., Willis, A. C., & Reid, K. B. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7763 · Cited by 351
Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin)
Wiltzius, J. J. W., Sievers, S. A., Sawaya, M. R., Cascio, D., Popov, D., Riekel, C., & Eisenberg, D. S. (2008) · Protein Science · doi:10.1110/ps.036509.108 · Cited by 326
Conserved and Cooperative Assembly of Membrane-Bound α-Helical States of Islet Amyloid Polypeptide
Knight, J. D., Hebda, J. A., & Miranker, A. D. (2006) · Biochemistry · doi:10.1021/bi060579z · Cited by 310
Ratner, R. E., Dickey, R., Fineman, M., Maggs, D. G., Shen, L., Strobel, S. A., Weyer, C., & Kolterman, O. G. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01319.x · Cited by 307
Opie, E. L. (1901) · Journal of Experimental Medicine · doi:10.1084/jem.5.5.527 · Cited by 305
Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology
Jaikaran, E. T. A. S., & Clark, A. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00078-3 · Cited by 298
Anguiano, M., Nowak, R. J., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi020314u · Cited by 293
Polymorphic Fibrillar Assembly of Human Amylin
Goldsbury, C. S., Cooper, G. J. S., Goldie, K. N., Müller, S. A., Saafi, E. L., Gruijters, W. T. M., Misur, M. P., Engel, A. H., Aebi, U., & Kistler, J. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3858 · Cited by 293
Protein Stabilization by Macromolecular Crowding through Enthalpy Rather Than Entropy
Senske, M., Törk, L., Born, B., Havenith, M., Herrmann, C., & Ebbinghaus, S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503205y · Cited by 285
Shtilerman, M. D., Ding, T. T., & Lansbury, P. T. (2002) · Biochemistry · doi:10.1021/bi0120906 · Cited by 280
Nanga, R. P. R., Brender, J., Vivekanandan, S., & Ramamoorthy, A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.06.012 · Cited by 278
Muff, R., Bühlmann, N., Fischer, J. A., & Born, W. (1999) · Endocrinology · doi:10.1210/endo.140.6.6930 · Cited by 273
Lipid Membranes Modulate the Structure of Islet Amyloid Polypeptide
Jayasinghe, S. A., & Langen, R. (2005) · Biochemistry · doi:10.1021/bi050840w · Cited by 262
An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing.
Sanke, T., Bell, G. I., Sample, C. E., Rubenstein, A. H., & Steiner, D. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77825-9 · Cited by 258
Sparr, E., Engel, M. F. M., Sakharov, D. V., Sprong, M., Jacobs, J., KRUIJFF, B. D., Höppener, J. W. M., & Killian, J. A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.075 · Cited by 257
Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet
Buchanan, L. E., Dunkelberger, E. B., Tran, H. Q., Cheng, P.-N., Chiu, C.-C., Cao, P., Raleigh, D., de Pablo, J. D., Nowick, J., & Zanni, M. (2013) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1314481110 · Cited by 251
Self-citationYan, L., Tatarek‐Nossol, M., Velkova, A., Kazantzis, A., & Kapurniotu, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507471103 · Cited by 247
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 242
Physical and structural basis for polymorphism in amyloid fibrils
Tycko, R. (2014) · Protein Science · doi:10.1002/pro.2544 · Cited by 241
Evidence for Proteotoxicity in β Cells in Type 2 Diabetes
Gurlo, T., Ryazantsev, S., Huang, C.-J., Yeh, M. W., Reber, H. A., Hines, O. J., O’Brien, T. D., Glabe, C. G., & Butler, P. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090532 · Cited by 234
Brender, J., Lee, E. L., Cavitt, M. A., Gafni, A., Steel, D. G., & Ramamoorthy, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710484d · Cited by 229
Hebda, J. A., & Miranker, A. D. (2009) · Annual Review of Biophysics · doi:10.1146/annurev.biophys.050708.133622 · Cited by 223
The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells
Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S., & Cooper, G. J. S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05367.x · Cited by 219
Zraika, S., Hull, R. L., Udayasankar, J., Aston‐Mourney, K., Subramanian, S. L., Kisilevsky, R., Szarek, W. A., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1255-x · Cited by 215
Direct detection of transient α‐helical states in islet amyloid polypeptide
Williamson, J. A., & Miranker, A. D. (2006) · Protein Science · doi:10.1110/ps.062486907 · Cited by 215
den Kamp, J. A. F. O., & Roelofsen, B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89065-9 · Cited by 213
Wiltzius, J. J. W., Sievers, S. A., Sawaya, M. R., & Eisenberg, D. S. (2009) · Protein Science · doi:10.1002/pro.145 · Cited by 208
Mechanisms of islet amyloidosis toxicity in type 2 diabetes
Abedini, A., & Schmidt, A. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.017 · Cited by 206
Self-citationAndreetto, E., Yan, L., Tatarek‐Nossol, M., Velkova, A., Frank, R., & Kapurniotu, A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904902 · Cited by 203
Westwell-Roper, C. Y., Dai, D. L., Soukhatcheva, G., Potter, K. J., van Rooijen, N., Ehses, J. A., & Verchere, C. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002854 · Cited by 193
Impact of reconstituted cytosol on protein stability
Sarkar, M., Smith, A. E., & Pielak, G. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312678110 · Cited by 191
Zraika, S., Hull, R. L., Verchere, C. B., Clark, A., Potter, K. J., Fraser, P. E., Raleigh, D. P., & Kahn, S. E. (2010) · Diabetologia · doi:10.1007/s00125-010-1671-6 · Cited by 191
Self-citationEffects of beta cell granule components on human islet amyloid polypeptide fibril formation
Westermark, P., Li, Z.-C., Westermark, G. T., Leckström, A., & Steiner, D. F. (1996) · FEBS Letters · doi:10.1016/0014-5793(95)01512-4 · Cited by 191
Widespread Amyloid Deposition in Transplanted Human Pancreatic Islets
Westermark, G. T., Westermark, P., Berne, C., & Korsgren, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0802893 · Cited by 187
Williamson, J. A., Loria, J. P., & Miranker, A. D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.077 · Cited by 186
Mazor, Y., Gilead, S., Benhar, I., & Gazit, E. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00887-2 · Cited by 186
The role of amylin in the control of energy homeostasis
Lutz, T. A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00703.2009 · Cited by 181
Betsholtz, C., Christmanson, L., Engström, U., Rorsman, F., Svensson, V., Johnson, K. H., & Westermark, P. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81467-x · Cited by 180
Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicity
Cao, P., Marek, P., Noor, H., Patsalo, V., Tu, L., Wang, H., Abedini, A., & Raleigh, D. P. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.046 · Cited by 178
Self-citationAbedini, A., Meng, F., & Raleigh, D. P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072157y · Cited by 178
Self-citationThe Human Islet Amyloid Polypeptide Forms Transient Membrane-Active Prefibrillar Assemblies
Porat, Y., Kolusheva, S., Jelinek, R., & Gazit, E. (2003) · Biochemistry · doi:10.1021/bi034889i · Cited by 174
Structures of Rat and Human Islet Amyloid Polypeptide IAPP1−19 in Micelles by NMR Spectroscopy
Nanga, R. P. R., Brender, J., Xu, J., Veglia, G., & Ramamoorthy, A. (2008) · Biochemistry · doi:10.1021/bi8014357 · Cited by 172
The internal pH and membrane potential of the insulin-secretory granule
Hutton, J. C. (1982) · Biochemical Journal · doi:10.1042/bj2040171 · Cited by 171
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts
Potter, K. J., Abedini, A., Marek, P., Klimek-Abercrombie, A. M., Butterworth, S. A., Driscoll, M., Baker, R. L., Nilsson, M. R., Warnock, G. L., Oberholzer, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909024107 · Cited by 171
Self-citationRoth, J. D., Hughes, H., Kendall, E. S., Baron, A., & Anderson, C. M. (2006) · Endocrinology · doi:10.1210/en.2006-0393 · Cited by 171
Marek, P., Patsalo, V., Green, D. F., & Raleigh, D. P. (2012) · Biochemistry · doi:10.1021/bi300574r · Cited by 168
Self-citationMissense Mutation of Amylin Gene (S20G) in Japanese NIDDM Patients
Sakagashira, S., Sanke, T., Hanabusa, T., Shimomura, H., Ohagi, S., Kumagaye, K. Y., Nakajima, K., & Nanjo, K. (1996) · Diabetes · doi:10.2337/diab.45.9.1279 · Cited by 162
The Role of His-18 in Amyloid Formation by Human Islet Amyloid Polypeptide
Abedini, A., & Raleigh, D. P. (2005) · Biochemistry · doi:10.1021/bi051432v · Cited by 158
Self-citationCasas, S., Gomis, R., Gribble, F. M., Altirriba, J., Knuutila, S., & Novials, A. (2007) · Diabetes · doi:10.2337/db07-0178 · Cited by 148
Brender, J., Hartman, K. L., Reid, K. R., Kennedy, R. T., & Ramamoorthy, A. (2008) · Biochemistry · doi:10.1021/bi801427c · Cited by 147
Nanga, R. P. R., Brender, J., Xu, J., Hartman, K. L., Vivekanandan, S., & Ramamoorthy, A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9010095 · Cited by 147
Islet amyloid polypeptide toxicity and membrane interactions
Cao, P., Abedini, A., Wang, H., Tu, L.-H., Zhang, X., Schmidt, A. M., & Raleigh, D. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305517110 · Cited by 146
Self-citationNilsson, M. R., & Raleigh, D. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3286 · Cited by 146
Self-citationMatveyenko, A. V., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db05-1672 · Cited by 144
Sakagashira, S., Hiddinga, H. J., Tateishi, K., Sanke, T., Hanabusa, T., Nanjo, K., & Eberhardt, N. L. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64848-1 · Cited by 142
Marek, P., Abedini, A., Song, B., Kanungo, M., Johnson, M. E., Gupta, R., Zaman, W., Wong, S. S., & Raleigh, D. P. (2007) · Biochemistry · doi:10.1021/bi0621967 · Cited by 142
Self-citationHyperamylinemia Contributes to Cardiac Dysfunction in Obesity and Diabetes
Despa, S. I., Margulies, K. B., Chen, L., Knowlton, A. A., Havel, P. J., Taegtmeyer, H., Bers, D. M., & Despa, F. (2012) · Circulation Research · doi:10.1161/circresaha.111.258285 · Cited by 137
Rivera, J. F., Gurlo, T., Daval, M., Huang, C. J., Matveyenko, A. V., Butler, P. C., & Costes, S. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.111 · Cited by 136
Fibril Structure of Human Islet Amyloid Polypeptide*♦
Bedrood, S., Li, Y.-Y., Isas, J., Hegde, B. G., Baxa, U., Haworth, I., & Langen, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.327817 · Cited by 136
Role of Aromatic Interactions in Amyloid Formation by Islet Amyloid Polypeptide
Tu, L., & Raleigh, D. P. (2012) · Biochemistry · doi:10.1021/bi3014278 · Cited by 135
Self-citationIslet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity
Last, N. B., Rhoades, E. R., & Miranker, A. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102356108 · Cited by 132
Full-length Rat Amylin Forms Fibrils Following Substitution of Single Residues from Human Amylin
Green, J., Goldsbury, C. S., Mini, T., Sunderji, S., Frey, P., Kistler, J., Cooper, G. J. S., & Aebi, U. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01377-3 · Cited by 127
Role of Aromatic Interactions in Amyloid Formation by Peptides Derived from Human Amylin
Tracz, S. M., Abedini, A., Driscoll, M., & Raleigh, D. P. (2004) · Biochemistry · doi:10.1021/bi048812l · Cited by 127
Self-citationNilsson, M. R., Driscoll, M., & Raleigh, D. P. (2002) · Protein Science · doi:10.1110/ps.48702 · Cited by 124
Self-citationProtein Crowder Charge and Protein Stability
Sarkar, M., Lu, J., & Pielak, G. J. (2014) · Biochemistry · doi:10.1021/bi4016346 · Cited by 124
Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology
Cao, P., Abedini, A., & Raleigh, D. P. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.11.003 · Cited by 119
Self-citation2DIR Spectroscopy of Human Amylin Fibrils Reflects Stable β-Sheet Structure
Wang, L., Middleton, C. T., Singh, S., Reddy, A. S., Woys, A. M., Strasfeld, D. B., Marek, P., Raleigh, D. P., de Pablo, J. J., Zanni, M. T., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja204035k · Cited by 119
Self-citationAberrant Processing of Human Proislet Amyloid Polypeptide Results in Increased Amyloid Formation
Paulsson, J. F., & Westermark, G. T. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2117 · Cited by 118
Tsai, H. G., Reches, M., Tsai, C., Gunasekaran, K., Gazit, E., & Nussinov, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408653102 · Cited by 115
The Mechanism of Insulin Action on Islet Amyloid Polypeptide Fiber Formation
Larson, J. L., & Miranker, A. D. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.045 · Cited by 112
pH Dependence of Amylin Fibrillization
Jha, S., Snell, J. M., Sheftic, S. R., Patil, S. M., Daniels, S. B., Kolling, F. W., & Alexandrescu, A. T. (2013) · Biochemistry · doi:10.1021/bi401164k · Cited by 112
Zhang, S., Liu, J., Dragunow, M., & Cooper, G. J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308244200 · Cited by 111
Jaikaran, E. T. A. S., Nilsson, M. R., & Clark, A. (2004) · Biochemical Journal · doi:10.1042/bj20030852 · Cited by 109
Abedini, A., & Raleigh, D. P. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.052 · Cited by 106
Self-citationDeamidation Accelerates Amyloid Formation and Alters Amylin Fiber Structure
Dunkelberger, E. B., Buchanan, L. E., Marek, P., Cao, P., Raleigh, D. P., & Zanni, M. T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3039486 · Cited by 104
Self-citationWang, Z.-L., Bennet, W. M., Ghatei, M. A., BYFIELD, P. G. H., Smith, D. M., & Bloom, S. R. (1993) · Diabetes · doi:10.2337/diab.42.2.330 · Cited by 103
The Contrasting Effect of Macromolecular Crowding on Amyloid Fibril Formation
Ma, Q., Fan, J.-B., Zhou, Z., Zhou, B., Meng, S.-R., Hu, J.-Y., Chen, J., & Liang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036288 · Cited by 102
Bailey, R., Walker, C. S., Ferner, A. H., Loomes, K., Prijic, G., Halim, A., Whiting, L., Phillips, A., & Hay, D. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01717.x · Cited by 102
Marzban, L., Rhodes, C. J., Steiner, D. F., Haataja, L., Halban, P. A., & Verchere, C. B. (2006) · Diabetes · doi:10.2337/db05-1566 · Cited by 101
CENTRAL AMYLIN ACTS AS AN ADIPOSITY SIGNAL TO CONTROL BODY WEIGHT AND ENERGY EXPENDITURE
Wielinga, P., Löwenstein, C., Muff, S., Munz, M., Woods, S. C., & Lutz, T. (2010) · Physiology and Behavior · doi:10.1016/j.physbeh.2010.04.012 · Cited by 100
Park, K., & Verchere, C. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008423200 · Cited by 99
Metabolic stress, IAPP and islet amyloid
Montane, J., Klimek‐Abercrombie, A., Potter, K. J., Westwell‐Roper, C., & Bruce Verchere, C. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01657.x · Cited by 98
Molecular Mapping of the Recognition Interface between the Islet Amyloid Polypeptide and Insulin
Gilead, S., Wolfenson, H., & Gazit, E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602034 · Cited by 96
Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes
Huang, C., Gurlo, T., Haataja, L., Costes, S., Daval, M., Ryazantsev, S., Wu, X., Butler, A. E., & Butler, P. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024190 · Cited by 95
Brainstem mechanisms of amylin-induced anorexia
Potes, C. S., & Lutz, T. A. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.001 · Cited by 93
Young, I. D., Ailles, L., Narindrasorasak, S., Tan, R., & Kisilevsky, R. (1992) · PubMed · Cited by 92
Bram, Y., Frydman‐Marom, A., Yanai, I., Gilead, S., Shaltiel‐Karyo, R., Amdursky, N., & Gazit, E. (2014) · Scientific Reports · doi:10.1038/srep04267 · Cited by 89
Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro
CHARGÉ, S. B. P., de Koning, E. J. P., & Clark, A. (1995) · Biochemistry · doi:10.1021/bi00044a038 · Cited by 89
Scrocchi, L. A., Ha, K., Chen, Y., Wu, L., Wang, F., & Fraser, P. E. (2003) · Journal of Structural Biology · doi:10.1016/s1047-8477(02)00630-5 · Cited by 87
Interaction of membrane‐bound islet amyloid polypeptide with soluble and crystalline insulin
Knight, J. D., Williamson, J. A., & Miranker, A. D. (2008) · Protein Science · doi:10.1110/ps.036350.108 · Cited by 86
Sensitivity of Amyloid Formation by Human Islet Amyloid Polypeptide to Mutations at Residue 20
Cao, P., Tu, L., Abedini, A., Levsh, O., Akter, R., Patsalo, V., Schmidt, A. M., & Raleigh, D. P. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.032 · Cited by 85
Self-citationGanglioside‐induced amyloid formation by human islet amyloid polypeptide in lipid rafts
Wakabayashi, M., & Matsuzaki, K. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.044 · Cited by 78
Trikha, S., & Jeremic, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240762 · Cited by 75
Subramanian, S. L., Hull, R. L., Zraika, S., Aston‐Mourney, K., Udayasankar, J., & Kahn, S. E. (2011) · Diabetologia · doi:10.1007/s00125-011-2338-7 · Cited by 75
Weise, K., Radovan, D., Gohlke, A., Opitz, N., & Winter, R. (2010) · ChemBioChem · doi:10.1002/cbic.201000039 · Cited by 74
Marzban, L., Trigo‐Gonzalez, G., & Verchere, C. B. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0407 · Cited by 74
B Cell Granule Peptides Affect Human Islet Amyloid Polypeptide (IAPP) Fibril Formationin Vitro
Janciauskiene, S. M., Eriksson, S., Carlemalm, E., & Åhrén, B. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7014 · Cited by 73
Udayasankar, J., Kodama, K., Hull, R. L., Zraika, S., Aston‐Mourney, K., Subramanian, S. L., Tong, J., Faulenbach, M. V., Vidal, J., & Kahn, S. E. (2008) · Diabetologia · doi:10.1007/s00125-008-1185-7 · Cited by 71
Macromolecular Crowding as a Suppressor of Human IAPP Fibril Formation and Cytotoxicity
Seeliger, J., Werkmüller, A., & Winter, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069652 · Cited by 71
Ashburn, T. T., & Lansbury, P. T. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00076a078 · Cited by 71
Pramlintide for the Treatment of Insulin-Requiring Diabetes Mellitus
Kruger, D. F., & Gloster, M. (2004) · Drugs · doi:10.2165/00003495-200464130-00003 · Cited by 70
Mechanism of Amylin Fibrillization Enhancement by Heparin
Jha, S., Patil, S. M., Gibson, J. D., Nelson, C. E., Alder, N. N., & Alexandrescu, A. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215814 · Cited by 70
Insights into amylin–leptin synergy
Trevaskis, J. L., Parkes, D. G., & Roth, J. D. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.03.006 · Cited by 69
Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide
Ma, Z., Westermark, G., Sakagashira, S., Sanke, T., Gustavsson, Å., Sakamoto, H., Engström, U., Nanjo, K., & Westermark, P. (2001) · Amyloid: Journal of Protein Folding Disorders · doi:10.3109/13506120108993820 · Cited by 69
Hull, R. L., Zraika, S., Udayasankar, J., Aston‐Mourney, K., Subramanian, S. L., & Kahn, S. E. (2009) · Diabetologia · doi:10.1007/s00125-009-1329-4 · Cited by 67
Fox, A., Snollaerts, T., Casanova, C. E., Calciano, A., Nogaj, L. A., & Moffet, D. A. (2010) · Biochemistry · doi:10.1021/bi100337p · Cited by 67
Stridsberg, M., Sandler, S., & Wilander, E. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90362-c · Cited by 65
Saafi, E. L., Konarkowska, B., Zhang, S., Kistler, J., & Cooper, G. J. S. (2001) · Cell Biology International · doi:10.1006/cbir.2000.0643 · Cited by 65
Brunham, L. R., Kruit, J. K., Hayden, M. R., & Verchere, C. B. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0090-x · Cited by 63
Modulation of human IAPP fibrillation: cosolutes, crowders and chaperones
Gao, M., Estel, K., Seeliger, J., Friedrich, R. P., Dogan, S., Wanker, E. E., Winter, R., & Ebbinghaus, S. (2014) · Physical Chemistry Chemical Physics · doi:10.1039/c4cp04682j · Cited by 62
The interaction of amylin with other hormones in the control of eating
Lutz, T. A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01670.x · Cited by 61
Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide
Koo, B. W., Hebda, J. A., & Miranker, A. D. (2008) · Protein Engineering Design and Selection · doi:10.1093/protein/gzm076 · Cited by 60
Cardioprotection by Controlling Hyperamylinemia in a “Humanized” Diabetic Rat Model
Despa, S. I., Sharma, S., Harris, T. R., Dong, H., Li, N., Chiamvimonvat, N., Taegtmeyer, H., Margulies, K. B., Hammock, B. D., & Despa, F. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001015 · Cited by 60
Aston‐Mourney, K., Hull, R. L., Zraika, S., Udayasankar, J., Subramanian, S. L., & Kahn, S. E. (2011) · Diabetologia · doi:10.1007/s00125-011-2143-3 · Cited by 59
The Effect of Aβ on IAPP Aggregation in the Presence of an Isolated β-Cell Membrane
Seeliger, J., Weise, K., Opitz, N., & Winter, R. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.048 · Cited by 59
Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide
Park, Y. J., Lee, S., Kieffer, T. J., Warnock, G. L., Safikhan, N., Speck, M., Hao, Z., Woo, M., & Marzban, L. (2012) · Diabetologia · doi:10.1007/s00125-012-2451-2 · Cited by 58
Radovan, D., Smirnovas, V., & Winter, R. (2008) · Biochemistry · doi:10.1021/bi800503j · Cited by 58
Adjunct therapy for type 1 diabetes mellitus
Lebovitz, H. E. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.49 · Cited by 57
Meng, F., Abedini, A., Song, B., & Raleigh, D. P. (2007) · Biochemistry · doi:10.1021/bi7004834 · Cited by 56
Self-citationYan, L.-M., Velkova, A., Tatarek-Nossol, M., Rammes, G., Sibaev, A., Andreetto, E., Kracklauer, M., Bakou, M., Malideli, E., Göke, B., et al. (2013) · Angewandte Chemie · doi:10.1002/anie.201302840 · Cited by 55
Gao, M., & Winter, R. (2015) · Journal of Diabetes Research · doi:10.1155/2015/849017 · Cited by 54
Hull, R. L., Zraika, S., Udayasankar, J., Kisilevsky, R., Szarek, W. A., Wight, T. N., & Kahn, S. E. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00208.2007 · Cited by 53
Meng, F., Raleigh, D. P., & Abedini, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1046186 · Cited by 50
Self-citationEemergence of Promising Therapies in Diabetes Mellitus
Akkati, S., Sam, K. G., & Tungha, G. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010376972 · Cited by 49
Human IAPP amyloidogenic properties and pancreatic β-cell death
Fernández, M. S. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.08.011 · Cited by 48
Further Evidence for Amyloid Deposition in Clinical Pancreatic Islet Grafts
Westermark, G. T., Davalli, A. M., Secchi, A., Folli, F. B., Kin, T., Toso, C., Shapiro, A. M. J., Korsgren, O., Tufveson, G., Andersson, A., et al. (2011) · Transplantation · doi:10.1097/tp.0b013e31823e46ef · Cited by 48
Wineman‐Fisher, V., Atsmon‐Raz, Y., & Miller, Y. (2014) · Biomacromolecules · doi:10.1021/bm501326y · Cited by 47
Zhang, S., Liu, H., Chuang, C.-L., Li, X., Au, M., Zhang, L., Phillips, A. R. J., Scott, D. W., & Cooper, G. J. S. (2014) · The FASEB Journal · doi:10.1096/fj.14-251744 · Cited by 46
Li, Y., Xu, W., Mu, Y., & Zhang, J. Z. H. (2013) · The Journal of Chemical Physics · doi:10.1063/1.4817000 · Cited by 46
Velkova, A., Tatarek‐Nossol, M., Andreetto, E., & Kapurniotu, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200801499 · Cited by 45
The Role of the 14–20 Domain of the Islet Amyloid Polypeptide in Amyloid Formation
Gilead, S., & Gazit, E. (2008) · Journal of Diabetes Research · doi:10.1155/2008/256954 · Cited by 45
Kowalczyk, R., Brimble, M. A., Tomabechi, Y., Fairbanks, A. J., Fletcher, M. M., & Hay, D. L. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob01208a · Cited by 41
Wang, H., Abedini, A., Ruzsicska, B. P., & Raleigh, D. P. (2014) · Biochemistry · doi:10.1021/bi500592p · Cited by 41
Self-citationLaw, E., Lu, S., Kieffer, T. J., Warnock, G. L., Ao, Z., Woo, M., & Marzban, L. (2010) · Diabetologia · doi:10.1007/s00125-010-1717-9 · Cited by 39
A Membrane‐Bound Antiparallel Dimer of Rat Islet Amyloid Polypeptide
Nath, A., Miranker, A. D., & Rhoades, E. R. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201102887 · Cited by 39
Autophagy protects against human islet amyloid polypeptide‐associated apoptosis
Morita, S., Sakagashira, S., Shimajiri, Y., Eberhardt, N. L., Kondo, T., Kondo, T., & Sanke, T. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00065.x · Cited by 36
Amide Proton Solvent Protection in Amylin Fibrils Probed by Quenched Hydrogen Exchange NMR
Alexandrescu, A. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056467 · Cited by 35
Tu, L., Serrano, A. L., Zanni, M. T., & Raleigh, D. P. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.12.052 · Cited by 34
Self-citationWestermark, G. T., & Westermark, P. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08298.x · Cited by 33
Turn Nucleation Perturbs Amyloid β Self-Assembly and Cytotoxicity
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.055 · Cited by 32
Fiber-Dependent and -Independent Toxicity of Islet Amyloid Polypeptide
Schlamadinger, D. E., & Miranker, A. D. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.09.047 · Cited by 32
High Plasma Levels of Islet Amyloid Polypeptide in Young with New-Onset of Type 1 Diabetes Mellitus
Paulsson, J., Ludvigsson, J., Carlsson, A., Casas, R., Forsander, G., Ivarsson, S., Kockum, I., Lernmark, Å., Marcus, C., Lindblad, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093053 · Cited by 32
Vidal, J., Verchere, C. B., Andrikopoulos, S., Wang, F., Hull, R. L., Cnop, M., Olin, K., LeBoeuf, R. C., O’Brien, K. D., Chait, A., et al. (2003) · Diabetologia · doi:10.1007/s00125-002-0984-5 · Cited by 30
Is type 2 diabetes an amyloidosis and does it really matter (to patients)?
Cooper, G. J. S., Aitken, J. F., & Zhang, S. (2010) · Diabetologia · doi:10.1007/s00125-010-1715-y · Cited by 29
Cholesterol modulates the interaction of the islet amyloid polypeptide with membranes
Caillon, L., Duma, L., Lequin, O., & Khemtémourian, L. (2014) · Molecular Membrane Biology · doi:10.3109/09687688.2014.987182 · Cited by 27
Islet amyloid and type 2 diabetes: overproduction or inadequate clearance and detoxification?
Gupta, D., & Leahy, J. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77506 · Cited by 27
Inhibition of insulin secretion.
Young, A. (2005) · Advances in Pharmacology · doi:10.1016/s1054-3589(05)52009-x · Cited by 24
Wang, H., & Raleigh, D. P. (2014) · Biochemistry · doi:10.1021/bi4015488 · Cited by 24
Self-citationCharge-Based Inhibitors of Amylin Fibrillization and Toxicity
Patil, S. M., & Alexandrescu, A. T. (2015) · Journal of Diabetes Research · doi:10.1155/2015/946037 · Cited by 17
Amylin Conjugation with Methoxyl Polyethyleneglycol
Guterres, M. F. A. N., Guerreiro, L. H., Melo-Ferreira, B., Erthal, L. C. S., & Lima, L. T. R. (2013) · Protein and Peptide Letters · doi:10.2174/09298665113209990067 · Cited by 9
Role of Posttranslational Modifications in Amyloid Formation
Abedini, A., Gupta, R., Marek, P., Meng, F., Raleigh, D. P., Taskent‐Sezgin, H., & Tracz, S. M. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch7 · Cited by 7
Self-citation
Flagged first, then by citations
1 of the 181 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- 2010, Angewandte Chemie International Edition, 45, 6476
- 10.1210/en.140.6.2924 · DOI · Paper page
- 10.1021/bi00044a038 · DOI
- 1992, Archives of Pathology and Laboratory Medicine, 116, 951
- 10.1210/en.143.2.339 · DOI · Paper page
- 2005, Current Opinion in Endocrinology and Diabetes, 12, 303
Cited by
Sorted by citations
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Domínguez, L., Shea, J., Dokholyan, N. V., Simone, A. D., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 680
Nanozymes expanding the boundaries of biocatalysis
Zhang, R., Yan, X., Gao, L., & Fan, K. (2025) · Nature Communications · doi:10.1038/s41467-025-62063-8 · Cited by 259
Bharadwaj, P., Wijesekara, N., Liyanapathirana, M., Newsholme, P., Ittner, L. M., Fraser, P. E., & Verdile, G. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161192 · Cited by 209
Milardi, D., Gazit, E., Radford, S. E., Xu, Y., Gallardo, R. U., Caflisch, A., Westermark, G. T., Westermark, P., Rosa, C. L., & Ramamoorthy, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00981 · Cited by 199
Effects of in vivo conditions on amyloid aggregation
Owen, M. C., Gnutt, D., Gao, M., Wärmländer, S. K. T. S., Jarvet, J., Gräslund, A., Winter, R., Ebbinghaus, S., & Strodel, B. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00034d · Cited by 181
Metadata
- Authors
- Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., & Raleigh, D. P.
- Affiliations
- Stony Brook University (US)
- NYU Langone Health (US)
- University College London (GB)
- Corresponding author
- Raleigh, Daniel P.
- ORCID
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-18
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- PMC
- PMC4662979
- OpenAlex
- W2209022283
- Cited by
- 273
- References
- 181
- Citations by year
- 2026: 23 · 2025: 33 · 2024: 37 · 2023: 14 · 2022: 26 · 2021: 32 · 2020: 36 · 2019: 21 · 2018: 28 · 2017: 13 · 2016: 10
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Diabetes Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (GM078114, 5T32GM09271405)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- amylin, islet amyloid, type 2 diabetes, beta-cell dysfunction, beta-cell death, islet transplantation, cardiovascular complications, type 1 diabetes, inflammasome, autophagy, endoplasmic reticulum stress, reactive oxygen species, glucose homeostasis
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Islets of Langerhans, Structure-Activity Relationship, Insulin-Secreting Cells, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review